Search results for: 'manufacture ai'

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...

Conversational AI solutions are designed to enhance communication and coordination among healthcare stakeholders. These voice and text applications automate human information gathering and communications and represent a growing opportunity for healthcare organizations to improve clinician efficiency, operational and administrative efficiency, healt...

This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and financial workflow integration. These capabilities inclu...

Traditional training environments face patient safety risks, resource constraints, and limited exposure to rare event scenarios. Additionally, physical simulations are costly, limiting accessibility (especially in resource-constrained settings). Current simulation models lack personalization, resulting in operational complexity for hospitals due to...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...